Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
120.5 USD | +0.98% | -2.54% | -7.96% |
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company benefits from high valuations in earnings multiples.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company appears highly valued given the size of its balance sheet.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Investment Management & Fund Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-7.96% | 91.48B | C- | ||
+24.13% | 91.26B | C+ | ||
+17.87% | 27.29B | B- | ||
-0.44% | 18.82B | - | B+ | |
+14.69% | 15.58B | B | ||
+5.63% | 15.46B | C+ | ||
-20.78% | 12.42B | C+ | ||
+21.20% | 9.94B | B | ||
+20.84% | 9.36B | C- | ||
+28.09% | 7.2B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- BX Stock
- Ratings Blackstone Inc.